Clinical trials of low dose naltrexone

Low-dose naltrexone (LDN) describes the off-label use of the medication has criticized these claims, pointing out a lack of clinical trials supporting them Published Clinical Trials of LDN (Low Dose Naltrexone)

21 Feb 2014 SELECTION CRITERIA: Randomized controlled trials of low dose The primary outcome was induction of clinical remission defined by a

The following clinical trials are currently actively researching the effects of Low Dose Naltrexone (LDN) in different disease conditions. For further details, please 5 May 2010 Recent claims made for low dose naltrexone (LDN) fit nicely into this the effect clinically insignificant, and therefore not seen in clinical trials A comprehensive and regularly updated list of all medical trial papers since the 1970s into the use of Low-Dose Naltrexone in treating various conditions

Low-dose naltrexone - Wikipedia, the free encyclopedia

Alpha-Lipoic Acid Plus Low-Dose Naltrexone Reviewed for Cancer Treatment Dr. Zia also noted two ongoing NIH-supported clinical trials of naltrexone in 11 Mar 2013 Subjects in this arm will recieve low dose naltrexone (4.5 mg) daily for 12 weeks. For general information, see Learn About Clinical Studies

8 Jul 2014 Low-dose naltrexone (LDN) is unlicensed to treat MS because it hasn39t undergone full clinical trials for the condition and is prescribed only by 3 May 2013 In Brief Recently Published Clinical Trials Clinical Trials in Progress Low-dose naltrexone for the treatment of fibromyalgia: Findings of a